Automated blood test strategy could spot hidden liver disease in routine checkups
NCT ID NCT07658755
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
LiverSeek is a study testing an automated screening program for advanced liver fibrosis in people aged 50-75 with risk factors like diabetes or obesity. When a routine blood test is done, the lab system automatically calculates a fibrosis score and, if needed, orders additional tests without the doctor having to act. The goal is to see how many high-risk patients have liver scarring and whether this approach can catch it early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
automated screening strategy using blood tests (FIB-4, ELF, MASEF) and nurse-led lifestyle intervention
What this could lead to
If successful, this could lead to a simple, automated way to catch liver fibrosis early in primary care, potentially preventing progression to severe liver disease.
What could go wrong
This is an observational screening study, not a treatment trial. It may not prove that early detection improves outcomes, and the lifestyle intervention sub-study is small.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital General Universitario Gregorio Marañón
RECRUITINGMadrid, Madrid, 28007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••